Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients

NCT05443932 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Urolithiasis
Hyperoxaluria

Interventions

DRUG: Dapagliflozin
DRUG: Hydrochlorothiazide

Sponsor

Medical University of Vienna